Submit Your Best Content to ISPE

ISPE’s official blog, iSpeak accepts contributions from our Members and professionals in the pharma industry.  

What We Look For 

iSpeak Blog
Industry guidance, including the ISPE Baseline® Guide: Commissioning and Qualification (Second Edition), describes an integrated, science and risk-based approach to commissioning and qualification (C&Q) designed to make effective use of engineering, vendor, and verification documentation while avoiding redundant testing. What is often more challenging in practice is how organizations implement...
iSpeak Blog

As pharmaceutical organizations expand cloud adoption, the challenge is no longer simply migrating individual applications. The opportunity is to establish reusable, governed cloud-platform capabilities that help teams deliver GxP-relevant systems with greater consistency, security, traceability, and operational resilience.

iSpeak Blog

Cannabidiol (CBD) presents a familiar, but demanding, drug-product problem: a highly lipophilic active molecule must be delivered through aqueous physiological environments, which can be reproduced. For prospective pain and inflammatory indications, formulation development therefore needs to distinguish carefully between improving the presentation of hydrophobic CBD and changing the...

iSpeak Blog

The professional community of pharmaceutical quality, validation, and compliance has recently lost one of its most respected figures. Reetu Chopra, a senior leader in computer systems validation (CSV) and a long standing contributor to ISPE’s GAMP® community, leaves behind a legacy defined by expertise, mentorship, and professional commitment.

iSpeak Blog

The 2026 ISPE Europe Annual Conference in Copenhagen, Denmark, this past April brought together professionals from across the globe with a shared goal: advancing pharmaceutical manufacturing and ultimately improving the quality of human life. At the center of this gathering was ISPE’s strategic vision, crafted with the guidance of the International Board of Directors and, importantly, written...

iSpeak Blog

In today’s pharmaceutical manufacturing environment, organizations are expected to do more than simply comply with regulations. Regulators, industry leaders, and patients increasingly expect pharmaceutical companies to build robust quality systems that consistently deliver safe, effective products while fostering continuous improvement across the organization. As a result, quality has evolved...

iSpeak Blog

Hepalink Pharmaceutical Group Co., Ltd. has earned recognition in the 2026 ISPE Facility of the Year Awards (FOYA) Innovation – Novel Technology category for its groundbreaking Shenzhen Hepalink Pingshan New Pre-filled Syringe Manufacturing Facility. The award recognizes facilities that demonstrate the innovative application of manufacturing technologies, facility design, and engineering...

iSpeak Blog

Pharmaceutical manufacturing requires effective monitoring and control to ensure product quality, patient safety, and regulatory compliance. Investigations often depend on manual data review and cross-functional collaboration, making root-cause identification time-consuming. Vision Artificial Intelligence (vision AI) offers an opportunity to transform manufacturing operations through...

iSpeak Blog
Current Good Manufacturing Practice (GMP) regulations clearly define expectations for commercial manufacturing and product release, while International Council for Harmonisation (ICH) Q8(R2) Pharmaceutical Development recognizes pharmaceutical development as the stage where process and product understanding are established and enhanced through a science- and risk-based approach. However, the...
iSpeak Blog

How can pharmaceutical companies meet ambitious sustainability targets while maintaining compliance, product quality, and operational performance? What strategies are organizations using to reduce carbon emissions, optimize water and energy consumption, and build more sustainable facilities? And how are industry leaders navigating evolving regulations; environmental, social, and governance...

iSpeak Blog

Human-in-the-Loop (HITL) is frequently cited as a central control mechanism in AI-supported GxP processes: humans are expected to safeguard outputs generated within artificial intelligence (AI) supported GxP processes through review, approval, or override. However, findings from human factors research, organizational psychology, and the automation bias literature show that human oversight...

iSpeak Blog

AstraZeneca’s Commercial Cell Therapy Facility in Rockville, Maryland is setting a new benchmark for how pharmaceutical manufacturers can deliver lifesaving therapies while simultaneously advancing sustainability and operational excellence. Recognized as the 2026 ISPE Facility of the Year Awards (FOYA) Social Impact – Unmet Medical Needs Category Winner, the facility demonstrates how...

iSpeak Blog
The 2022 revision of EU GMP Annex 1 has significantly increased regulatory focus on sterility assurance, contamination control strategies (CCS), and the technical justification of CQV activities for sterile manufacturing facilities. Concurrently, life sciences capital projects continue to face increasing pressure to reduce delivery timelines, driving interest in digital and AI–enabled tools to...
iSpeak Blog

Expanding active life sciences manufacturing facilities presents unique challenges, where production continuity, regulatory compliance and tight shutdown windows leave little margin for error. Traditional project delivery methods often rely on assumptions and field discovery, increasing the risk of rework, schedule delays and operational disruptions. This blog post explores how digital...

Subscribe to ISPE ISpeak Blogs